Stevanato Group SpA (STVN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stevanato Group SpA (STVN) has a cash flow conversion efficiency ratio of 0.062x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($92.46 Million) by net assets ($1.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Stevanato Group SpA - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Stevanato Group SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Stevanato Group SpA balance sheet liabilities for a breakdown of total debt and financial obligations.
Stevanato Group SpA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stevanato Group SpA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cydsa S.A.B. de C.V
MX:CYDSASAA
|
0.096x |
|
Mingchen Health Co Ltd Class A
SHE:002919
|
0.050x |
|
Piraeus Port Authority S.A
AT:PPA
|
0.158x |
|
Berliner Effektengesellschaft AG
F:BFV
|
N/A |
|
Shenzhen Grandland Decoration Group Co Ltd
SHE:002482
|
0.123x |
|
Xiandai Investment Co Ltd
SHE:000900
|
0.047x |
|
Guangzhou Metro Design And Research
SHE:003013
|
0.032x |
|
BW Offshore Ltd
OL:BWO
|
0.266x |
Annual Cash Flow Conversion Efficiency for Stevanato Group SpA (2019–2025)
The table below shows the annual cash flow conversion efficiency of Stevanato Group SpA from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Stevanato Group SpA (STVN) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.49 Billion | $274.79 Million | 0.185x | +66.71% |
| 2024-12-31 | $1.40 Billion | $155.78 Million | 0.111x | +19.41% |
| 2023-12-31 | $1.13 Billion | $105.21 Million | 0.093x | -10.45% |
| 2022-12-31 | $995.91 Million | $103.30 Million | 0.104x | -34.51% |
| 2021-12-31 | $841.66 Million | $133.30 Million | 0.158x | -68.44% |
| 2020-12-31 | $310.14 Million | $155.66 Million | 0.502x | +212.93% |
| 2019-12-31 | $265.44 Million | $42.57 Million | 0.160x | -- |
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more